Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems
Authors
Keywords
-
Journal
DIABETIC MEDICINE
Volume 35, Issue 4, Pages 450-459
Publisher
Wiley
Online
2018-01-16
DOI
10.1111/dme.13581
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
- (2017) Firas H El-Khatib et al. LANCET
- Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
- (2017) Alanna Weisman et al. Lancet Diabetes & Endocrinology
- Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home
- (2016) Eric Renard et al. DIABETES CARE
- Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide
- (2016) Jennifer L. Sherr et al. DIABETES CARE
- Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes
- (2016) A. Ranjan et al. DIABETES OBESITY & METABOLISM
- Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy
- (2016) P. G. Jacobs et al. DIABETES OBESITY & METABOLISM
- Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use
- (2016) Nadine Taleb et al. DIABETES OBESITY & METABOLISM
- Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial
- (2016) Nadine Taleb et al. DIABETOLOGIA
- Glucagon is the key factor in the development of diabetes
- (2016) Young H. Lee et al. DIABETOLOGIA
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes
- (2016) Ahmad Haidar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exercise-stimulated glucose uptake — regulation and implications for glycaemic control
- (2016) Lykke Sylow et al. Nature Reviews Endocrinology
- The role of glucagon in the artificial pancreas
- (2016) Ahmad Haidar et al. Lancet Diabetes & Endocrinology
- Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial
- (2016) Steven J Russell et al. Lancet Diabetes & Endocrinology
- Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System
- (2015) Jessica R. Castle et al. DIABETES CARE
- Evidence-Informed Clinical Practice Recommendations for Treatment of Type 1 Diabetes Complicated by Problematic Hypoglycemia
- (2015) Pratik Choudhary et al. DIABETES CARE
- Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
- (2015) Kellee M. Miller et al. DIABETES CARE
- Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels
- (2015) H. Blauw et al. DIABETES OBESITY & METABOLISM
- Home Use of an Artificial Beta Cell in Type 1 Diabetes
- (2015) Hood Thabit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial
- (2015) Ahmad Haidar et al. Lancet Diabetes & Endocrinology
- 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial
- (2015) Jort Kropff et al. Lancet Diabetes & Endocrinology
- Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial
- (2015) Ahmad Haidar et al. Lancet Diabetes & Endocrinology
- Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels
- (2014) Joseph El Youssef et al. DIABETES CARE
- Automated Control of an Adaptive Bihormonal, Dual-Sensor Artificial Pancreas and Evaluation During Inpatient Studies
- (2014) Peter G. Jacobs et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
- (2014) Steven J. Russell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial
- (2013) A. Haidar et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes
- (2013) J. L. Sherr et al. DIABETES CARE
- Feasibility of a Portable Bihormonal Closed-Loop System to Control Glucose Excursions at Home Under Free-Living Conditions for 48 Hours
- (2013) Arianne C. van Bon et al. Diabetes Technology & Therapeutics
- Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes
- (2013) Trang T. Ly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of Midday Moderate-Intensity Exercise on Postexercise Hypoglycemia Risk in Individuals With Type 1 Diabetes
- (2013) Raymond J. Davey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
- (2013) Richard M. Bergenstal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes
- (2012) A. Siafarikas et al. DIABETES CARE
- Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
- (2012) D. Elleri et al. DIABETES CARE
- Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
- (2012) S. A. Weinzimer et al. DIABETES CARE
- The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences
- (2012) P. D. Home DIABETES OBESITY & METABOLISM
- Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
- (2012) Roger H. Unger et al. JOURNAL OF CLINICAL INVESTIGATION
- Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes
- (2010) J. R. Castle et al. DIABETES CARE
- A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
- (2010) F. H. El-Khatib et al. Science Translational Medicine
- Barriers to Physical Activity Among Patients With Type 1 Diabetes
- (2008) A.-S. Brazeau et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation